Nisa Investment Advisors’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.2K Hold
149
﹤0.01% 2143
2025
Q4
$11.7K Buy
149
+111
+292% +$8.44K ﹤0.01% 2152
2025
Q3
$2.55K Buy
38
+22
+138% +$1.58K ﹤0.01% 2572
2025
Q2
$1.51K Sell
16
-5
-24% -$549 ﹤0.01% 2660
2025
Q1
$2.49K Hold
21
﹤0.01% 2411
2024
Q4
$2.77K Buy
21
+4
+24% +$491 ﹤0.01% 2400
2024
Q3
$2.21K Buy
17
+8
+89% +$941 ﹤0.01% 2376
2024
Q2
$781 Buy
9
+2
+29% +$209 ﹤0.01% 2575
2024
Q1
$768 Buy
+7
New +$705 ﹤0.01% 2418
2023
Q4
Sell
-6
Closed -$630 2702
2023
Q3
$630 Buy
6
+1
+20% +$128 ﹤0.01% 2481
2023
Q2
$643 Hold
5
﹤0.01% 2509
2023
Q1
$1K Hold
5
﹤0.01% 2420
2022
Q4
$1K Hold
5
﹤0.01% 2467
2022
Q3
$1K Sell
5
-2,025
-100% -$369K ﹤0.01% 2465
2022
Q2
$414K Buy
+2,030
New +$444K ﹤0.01% 1118
2021
Q2
Sell
-200
Closed -$49 2361
2021
Q1
$49 Sell
200
-325
-62% -$89.4K ﹤0.01% 1982
2020
Q4
$150K Buy
525
+450
+600% +$124K ﹤0.01% 1584
2020
Q3
$19K Hold
75
﹤0.01% 2040
2020
Q2
$16K Buy
+75
New +$17.3K ﹤0.01% 1827

Other funds holding MLAB

Nisa Investment Advisors's MLAB Position: Q1 2026 in Review

Nisa Investment Advisors held its Mesa Laboratories (MLAB) position steady in Q1 2026 at 149 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2143.

Nisa Investment Advisors first reported a position in MLAB in Q2 2020 and has held it in 19 quarters since. The position peaked at $414K in Q2 2022. 161 funds tracked by Wall St. Rank hold MLAB as of Q1 2026.

  • Nisa Investment Advisors held 149 shares of Mesa Laboratories worth $13.2K as of Q1 2026.
  • Nisa Investment Advisors left its Mesa Laboratories share count unchanged in Q1 2026.
  • Mesa Laboratories made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2143 holding.
  • Nisa Investment Advisors first reported a position in Mesa Laboratories in Q2 2020 and has held it in 19 quarters since.
  • Nisa Investment Advisors's Mesa Laboratories position peaked at $414K in Q2 2022.
  • 161 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.